Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Sporn

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Clinical Therapeutics|July 21, 2004
Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of actionMichael B Sporn, Sherie A Dowsett, John Mershon, et al.
Arthritis and Rheumatism|March 1, 2007
Regulation of matrix metalloproteinase gene expression by a retinoid X receptor-specific ligandPeter S Burrage, Jonathan T Huntington, Michael B Sporn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cellsEun-Hee Kim, Chu-Xia Deng, Michael B Sporn, et al.
The Journal of Biological Chemistry|March 7, 2002
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cellsTerrance A Stadheim, Nanjoo Suh, Neema Ganju, et al.
Journal of Neuroinflammation|May 14, 2008
The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotectionThi A Tran, Melissa K McCoy, Michael B Sporn, et al.
Carcinogenesis|September 24, 2016
The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancerAna S Leal, Michael B Sporn, Patricia A Pioli, et al.
Cancer Research|September 2, 2008
Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoidsRoberta Venè, Patrizia Larghero, Giuseppe Arena, et al.
Molecular Cancer Therapeutics|December 7, 2006
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase betaMark M Yore, Karen T Liby, Tadashi Honda, et al.
Organic & Biomolecular Chemistry|June 11, 2014
An efficient synthesis of methyl 2-cyano-3,12-dioxoursol-1,9-dien-28-oate (CDDU-methyl ester): analogues, biological activities, and comparison with oleanolic acid derivativesLiangfeng Fu, Qi-Xian Lin, Karen T Liby, et al.
Clinical Orthopaedics and Related Research|October 14, 2004
Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritisKimberlee S Mix, Michael B Sporn, Constance E Brinckerhoff, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Clinical Therapeutics|July 21, 2004
Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of actionMichael B Sporn, Sherie A Dowsett, John Mershon, et al.
Arthritis and Rheumatism|March 1, 2007
Regulation of matrix metalloproteinase gene expression by a retinoid X receptor-specific ligandPeter S Burrage, Jonathan T Huntington, Michael B Sporn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cellsEun-Hee Kim, Chu-Xia Deng, Michael B Sporn, et al.
The Journal of Biological Chemistry|March 7, 2002
The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cellsTerrance A Stadheim, Nanjoo Suh, Neema Ganju, et al.
Journal of Neuroinflammation|May 14, 2008
The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotectionThi A Tran, Melissa K McCoy, Michael B Sporn, et al.
Carcinogenesis|September 24, 2016
The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancerAna S Leal, Michael B Sporn, Patricia A Pioli, et al.
Cancer Research|September 2, 2008
Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoidsRoberta Venè, Patrizia Larghero, Giuseppe Arena, et al.
Molecular Cancer Therapeutics|December 7, 2006
The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase betaMark M Yore, Karen T Liby, Tadashi Honda, et al.
Organic & Biomolecular Chemistry|June 11, 2014
An efficient synthesis of methyl 2-cyano-3,12-dioxoursol-1,9-dien-28-oate (CDDU-methyl ester): analogues, biological activities, and comparison with oleanolic acid derivativesLiangfeng Fu, Qi-Xian Lin, Karen T Liby, et al.
Clinical Orthopaedics and Related Research|October 14, 2004
Novel inhibitors of matrix metalloproteinase gene expression as potential therapies for arthritisKimberlee S Mix, Michael B Sporn, Constance E Brinckerhoff, et al.
Pageof 12